Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Replimune Group Q1 EPS $(0.53) Down From $(0.44) YoY

Replimune Group (NASDAQ:REPL) reported quarterly losses of $(0.53) per share. This is a 20.45 percent decrease over losses of $(0.44) per share from the same period last year.

byBill Haddad

August 6, 2021

1 minute read

Replimune Group (NASDAQ:REPL) reported quarterly losses of $(0.53) per share. This is a 20.45 percent decrease over losses of $(0.44) per share from the same period last year.

Bally’s Shares Gain After Upbeat Preliminary Q2 Results

By Shivani Kumaresan

Today, 9:14 AM

Bally’s Corp (NYSE:BALY) reported preliminary second-quarter revenue estimates of $258 million – $268 million, versus the consensus of $225.36 million. Bally’s…

BALY

JP Morgan Maintains Overweight on Sage Therapeutics, Lowers Price Target to $60

By Benzinga Newsdesk

Today, 9:14 AM

JP Morgan analyst Anupam Rama maintains Sage Therapeutics (NASDAQ:SAGE) with a Overweight and lowers the price target from $92 to $60.

SAGE

Why Veru Stock Is Crashing Today?

By Vandana Singh

Today, 9:14 AM

The FDA declined to grant Veru Inc’s (NASDAQ:VERU) request for Emergency Use Authorization (EUA) for sabizabulin to treat hospitalized adult patients…

VERU